The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era

• DOI: 10.1080/00952990.2021.1979991
• Publication Date: 2021-10-21T03:25:07Z
• Authors: Ofer Amram; Solmaz Amiri; Victoria Panwala; Robert Lutz; Paul J. Joudrey; Eugenia Socias
• Keywords: Pandemic; 2019-20 coronavirus outbreak; Opiate Substitution Treatment

Background Background: In response to the COVID-19 pandemic, US Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an increase in methadone take-home doses treatment of Opioid Use Disorder (OUD) March 2020.